Finland granted marketing authorisation to Sativex, a cannabis-extract mouth spray containing THC and CBD. Neurologists may prescribe it for adults with moderate to severe spasticity caused by multiple sclerosis when other treatment has not worked.[1]
Listed for context. No score change is recorded for Finland here.
References
Checked. The date and the event were compared with a source that was read.